Volume 29, Issue 9 (12-2021)                   JSSU 2021, 29(9): 4057-4061 | Back to browse issues page


XML Persian Abstract Print


Abstract:   (1471 Views)
Introduction: With the development of interventional cardiology in the world, in addition to coronary and aortic diseases, the treatment of heart valve diseases through catheters has recently begun. The treatment of aortic stenosis (which was only possible with open surgery and valve replacement) was first performed in the world in 2002 by Alain Cribier in France with catheter insertion of the valve and was called Trans catheter Aortic valve implantation TAVI. Trans catheter Aortic valve implantation (TAVI) was performed in Iran in 2009 in the Heart Centre of Tehran and now is routinely performed by both Balloon Expanding and self-expanding valves. In addition, we do valve in valve implantation for degenarative biopresthetic valve, in all Heart valve positions too. The short and medium term results of this treatment were reviewed in the form of research projects and published in several articles. In this review, we have explained the initiating of this new procedure in our country with the following results.
Full-Text [PDF 593 kb]   (525 Downloads)    
Type of Study: Letter to editor | Subject: Cardiovascular
Received: 2021/05/22 | Accepted: 2021/12/1 | Published: 2021/12/1

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.